Catalent Hit With Patent Suit Over Epilepsy Drug Vimpat
The company that makes the anti-epileptic drug Vimpat has lodged a patent lawsuit against Catalent Pharma Solutions Inc. over allegations that it imported several shipments of a key ingredient to help...To view the full article, register now.
Already a subscriber? Click here to view full article